Zhejiang Benli Technology Co., Ltd. (301065.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 19.14

From 52W high−22.67%

Volume1.11M

Market capCNY 2.04B

P/E (TTM)25.8x

P/S (TTM)3.2x

Div yield—

Key dataSep 18, 2026

Open

CNY 19.14

From 52W high

−22.67%

Volume

1.11M

Market cap

CNY 2.04B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.9x

P/E (TTM)

25.8x

RSI (14)

47.9

MomentumView details →

1D Return

+0.16%

YTD Return

−10.49%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

25.8x

EV/EBITDA

9.9x

EV/Sales

2.4x

P/S (TTM)

3.2x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

23.65%

Net Margin

11.62%

EBITDA Margin

24.08%

ROE (TTM)

5.35%

ROA (TTM)

4.56%

Asset Turnover

0.39x

GrowthView details →

Revenue YoY

−6.46%

EPS YoY

+16.70%

FCF YoY

+1155.26%

Revenue CAGR 3Y

−5.59%

EPS CAGR 3Y

+10.72%

EBITDA YoY

—

MomentumView details →

1D Return

+0.16%

YTD Return

−10.49%

1Y Return

−18.26%

RSI (14)

47.9

vs 50D SMA

+1.62%

vs 200D SMA

−10.66%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

4.54x

Quick Ratio

4.02x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

638.51M

Net Income (TTM)

74.18M

Op. CF (TTM)

203.19M

Latest newsMore news →

Benli Technology received approval from Zhejiang Province Drug Administration to change its Drug Production License, allowing formal production of norfloxacin at its Linhai plant.12d ago

Benli Technology announced its first-half 2026 results: net profit attributable to shareholders was 44.7691 million yuan, up 0.24% year-on-year, with revenue of 370 million yuan, up 8.15%.28d ago

Similar companies

合金投资000633.SZ 大庆华科000985.SZ *ST天喻300205.SZ 森泰股份301429.SZ 新天药业002873.SZ 东南电子301359.SZ

Latest newsMore news →

Benli Technology received approval from Zhejiang Province Drug Administration to change its Drug Production License, allowing formal production of norfloxacin at its Linhai plant.12d ago Benli Technology announced its first-half 2026 results: net profit attributable to shareholders was 44.7691 million yuan, up 0.24% year-on-year, with revenue of 370 million yuan, up 8.15%.28d ago